Prenatal Testing for Fragile X Syndrome: CVS and Amniocentesis

Fragile X syndrome can be diagnosed prenatally via:

  1. Chorionic Villus Sampling (CVS): 10–13 weeks; placental biopsy. Miscarriage risk <1%.
  2. Amniocentesis: 15–20 weeks; amniotic fluid culture. Miscarriage risk <1%.

Testing targets the FMR1 CGG repeat expansion. Indicated for known carriers, family history, or abnormal prenatal screening. Genetic counseling is essential before and after testing to discuss implications and reproductive options.

Genetic Disorders - Related Articles